. 2016 Feb 1;89(1059):20150618. doi: 10.1259/bjr.20150618

Table 5.

p-values for Kaplan–Meier analysis according to each subtype using the log-rank test

Groups	Central		Peripheral
Groups	PFS	OS	PFS	OS
WB-MTV
LD/low MTV vs LD/high MTV	0.093	0.10	0.0005^a	0.0022^a
LD/low MTV vs ED/low MTV	0.056	0.0003^a	0.013	0.0036^a
LD/low MTV vs ED/high MTV	0.0002^a	<0.0001^a	<0.0001^a	<0.0001^a
LD/high MTV vs ED/low MTV	0.71	0.20	0.93	0.68
LD/high MTV vs ED/high MTV	0.078	0.030	0.82	0.54
ED/low MTV vs ED/high MTV	0.17	0.22	0.74	0.65
WB-TLG
LD/low TLG vs LD/high TLG	0.39	0.098	0.0005^a	0.0022^a
LD/low TLG vs ED/low TLG	0.036	0.0003^a	0.013	0.0036^a
LD/low TLG vs ED/high TLG	0.0002^a	<0.0001^a	<0.0001^a	<0.0001^a
LD/high TLG vs ED/low TLG	0.43	0.17	0.62	0.51
LD/high TLG vs ED/high TLG	0.078	0.033	0.70	0.56
ED/low TLG vs ED/high TLG	0.21	0.28	0.83	0.30

ED, extensive disease; LD, limited disease; MTV, metabolic tumour volume; OS, overall survival; PFS, progression-free survival; TLG, total lesion glycolysis; WB-MTV, whole-body metabolic tumour volume; WB-TLG, whole-body total lesion glycolysis.

^{^a}

p < 0.0083 (adjusted using the Bonferroni correction).